Mr Charles Garvey, CEO of Metabolomic Diagnostics will be attending the Society of Maternal Fetal Medicine (SMFM) Pregnancy meeting next week in Texas, USA.

The SMFM is a non-profit, membership organisation based in the US with more than 3,500 physicians, scientists and women’s health professionals around the world.  The Society supports the clinical practice of maternal-fetal medicine by providing education, promoting research and engaging in advocacy to optimise the health of high-risk pregnant women and their babies.

2020 marks the 40th annual pregnancy meeting for SMFM and will take place at Gaylord Texan Resort and Conference Center in Grapevine, Texas, near Dallas.  This meeting is the premier event for presenting and learning about cutting-edge science in obstetrics and provides participants the opportunity to connect with leaders and colleagues in maternal-fetal medicine.

About Metabolomic Diagnostics

Metabolomic Diagnostics is a biomarker-based company based in Little Island Cork, Ireland and is focused on developing a portfolio of tests for early stage pregnancy screening.

The company’s first product, PrePsiatm, is focused on Pre-term Preeclampsia screening for first time pregnancies which is an unmet clinical need.  This is a serious disease that can cause major disruption during pregnancy leading to the deaths of Mums and Babies and can have serious life-long consequences for the survivors.

https://www.smfm.org/

February 3-8th

Gaylord Texan Resort and Conference Center, Grapevine, Texas.

For further information: annmarie.barrett@metabdx.com